RenovoRx, Inc.
RNXT- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001574094
No open-market purchases or sales by RenovoRx, Inc. insiders were filed in the last 90 days; 28 institutions reported holding it in 13F filings for Q2 2026, worth $9.00M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding RenovoRx, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 10 | 17 | +7 |
| Shares | 329.7K | 895.2K | +565.6K (+171.6%) |
| Value | $441.6K | $1.01M | +$569.5K (+129.0%) |
New holders (8)
Institutions that held RenovoRx, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| ADAR1 Capital Management, LLC | 355,240 | $401.4K | 0.08% |
| Millennium Management LLC | 86,316 | $97.5K | 0.00% |
| Citadel Advisors LLC | 26,195 | $29.6K | 0.00% |
| HRT Financial LP | 11,743 | $13.0K | 0.00% |
| Renaissance Technologies LLC | 10,000 | $11.3K | 0.00% |
| UBS Group AG | 1,305 | $1.48K | 0.00% |
| Family Firm, Inc. | 1,000 | $1.13K | 0.00% |
| Bank of America Corp | 182 | $206 | 0.00% |
Sold out (1)
Institutions that held RenovoRx, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Wells Fargo & Company | 69 | $92 |